These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15950009)

  • 41. Molecular genetics of attention deficit hyperactivity disorder.
    Faraone SV; Mick E
    Psychiatr Clin North Am; 2010 Mar; 33(1):159-80. PubMed ID: 20159345
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ADHD pharmacogenetics across the life cycle: New findings and perspectives.
    Bruxel EM; Akutagava-Martins GC; Salatino-Oliveira A; Contini V; Kieling C; Hutz MH; Rohde LA
    Am J Med Genet B Neuropsychiatr Genet; 2014 Jun; 165B(4):263-82. PubMed ID: 24804845
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacogenetics informed decision making in adolescent psychiatric treatment: a clinical case report.
    Smith T; Sharp S; Manzardo AM; Butler MG
    Int J Mol Sci; 2015 Feb; 16(3):4416-28. PubMed ID: 25710722
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics.
    Turic D; Swanson J; Sonuga-Barke E
    Pharmgenomics Pers Med; 2010; 3():61-78. PubMed ID: 23226043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical pharmacogenetics in pediatric patients.
    Husain A; Loehle JA; Hein DW
    Pharmacogenomics; 2007 Oct; 8(10):1403-11. PubMed ID: 17979513
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacogenomics in practice: a case report of personalized inpatient psychiatric care.
    Madan A; Walker CR; Weinstein B; Fowler JC
    Pharmacogenomics; 2015; 16(5):433-9. PubMed ID: 25916515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emerging challenges in pharmacotherapy research on attention-deficit hyperactivity disorder-outcome measures beyond symptom control and clinical trials.
    Wong ICK; Banaschewski T; Buitelaar J; Cortese S; Döpfner M; Simonoff E; Coghill D;
    Lancet Psychiatry; 2019 Jun; 6(6):528-537. PubMed ID: 31122482
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic variation and pharmacogenomics in Alzheimer disease.
    Cacabelos R; Fernández-Novoa L; Lombardi V; Takeda M
    Seishin Shinkeigaku Zasshi; 2003; 105(1):47-67. PubMed ID: 12701212
    [No Abstract]   [Full Text] [Related]  

  • 49. Editorial: Brief research reports in pharmacogenetics and pharmacogenomics: 2022.
    Sessa F; Magdy T; Sukasem C; Patrinos GP
    Front Pharmacol; 2023; 14():1172265. PubMed ID: 36937855
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmacogenetic approach for a better drug treatment in children.
    Polanczyk G; Bigarella MP; Hutz MH; Rohde LA
    Curr Pharm Des; 2010; 16(22):2462-73. PubMed ID: 20513229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Associations between
    Brown JT; Beery N; Taran A; Stevens T; Henzler C; Badalamenti J; Regal R; McCarty CA
    Front Pediatr; 2022; 10():958622. PubMed ID: 36741090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The potential impact of pharmacogenetic testing on medication adherence.
    Haga SB; LaPointe NM
    Pharmacogenomics J; 2013 Dec; 13(6):481-3. PubMed ID: 23999596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of COMT in ADHD: a systematic meta-analysis.
    Sun H; Yuan F; Shen X; Xiong G; Wu J
    Mol Neurobiol; 2014 Feb; 49(1):251-61. PubMed ID: 23907791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacology and pharmacogenetics of pediatric ADHD with associated aggression: a review.
    Patel BD; Barzman DH
    Psychiatr Q; 2013 Dec; 84(4):407-15. PubMed ID: 23443759
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Occupational issues of adults with ADHD.
    Adamou M; Arif M; Asherson P; Aw TC; Bolea B; Coghill D; Guðjónsson G; Halmøy A; Hodgkins P; Müller U; Pitts M; Trakoli A; Williams N; Young S
    BMC Psychiatry; 2013 Feb; 13():59. PubMed ID: 23414364
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug therapy of attention deficit hyperactivity disorder: current trends.
    De Sousa A; Kalra G
    Mens Sana Monogr; 2012 Jan; 10(1):45-69. PubMed ID: 22654382
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder.
    Froehlich TE; Epstein JN; Nick TG; Melguizo Castro MS; Stein MA; Brinkman WB; Graham AJ; Langberg JM; Kahn RS
    J Am Acad Child Adolesc Psychiatry; 2011 Nov; 50(11):1129-1139.e2. PubMed ID: 22024001
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rodent versions of the iowa gambling task: opportunities and challenges for the understanding of decision-making.
    de Visser L; Homberg JR; Mitsogiannis M; Zeeb FD; Rivalan M; Fitoussi A; Galhardo V; van den Bos R; Winstanley CA; Dellu-Hagedorn F
    Front Neurosci; 2011; 5():109. PubMed ID: 22013406
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advances in understanding and treating ADHD.
    Antshel KM; Hargrave TM; Simonescu M; Kaul P; Hendricks K; Faraone SV
    BMC Med; 2011 Jun; 9():72. PubMed ID: 21658285
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.